C71T
CANCELLED SECTION 71
24/04/2026
Voltar para busca
Dado oficial do USPTO
ZYBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
22/05/2018
Data de registro
08/10/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/04/2026
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
98
Localização do titular
CN
Examinador
FENNESSY, EDWARD JOHN
Unidade examinadora
L10
Localização atual
TMEG LAW OFFICE 101
Descrição da marca
The mark consists of stylized word "zybio". Two partly-overlapping droplets are over the letter "b" and "i".
Titulares e representantes
Titulares
Zybio Inc.
Chongqing Zybio Inc. LTD.
Zybio Co., Ltd.
Representantes
Alex Patel Patel & Almeida, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Bacteriological preparations for medical and veterinary use; bacterial preparations for medical and veterinary use; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases; diagnostic preparations for medical purposes; chemical preparations for the diagnosis of pregnancy; antibiotics; vaccines; bacterial poisons
Classe 10
Apparatus for use in medical analysisblood cell analyzerblood flow analyzerblood glucose metercell analysis systemelectrolyte analysis systemelectrolyte and biochemical analysis systempolymerase chain reaction machine for clinicalmedical diagnostictherapeutic usesnucleic acid extractorenzyme label analyzerenzyme immunoassay analyzerglycated hemoglobin analyzer; diagnostic apparatus for medical purposesultrasound detection systemelectrocardiographchemiluminescence immunoanalyzer for analyzing blood serummedical apparatus and instruments for diagnostic radiopharmaceutical useblood coagulation detection systemdiagnostic apparatus for detecting bladder infectionsflow cytometers and flow-based analyzers providing cell and particle analysisdetectioncounting for medicalclinicalmedical diagnostictherapeutic usesdiagnostic kits consisting primarily of probesbuffers and reagents for use in microbial testingarteriosclerosis monitormedical diagnostic apparatus for testing and analyzing genital tract secretionapparatus for blood analysissample preparation device for medical diagnostic usescell culture apparatus for medical usecell culture chambers; apparatus for use in medical analysishematology analyzers for medical diagnostic usesimmunochemical testing apparatus for medical useautomatic biochemical analyzer for testing urinebloodfecessalivacerebrospinal fluid in medical usemass spectrometers for testing urinebloodfecessalivacerebrospinal fluid for medical use; medical apparatus and instrumentssurgical apparatus and instrumentssample preparation instrument; POCT analyzer in the nature of nursing appliancesmedical diagnostic apparatus for testing blood sugar levelsMedical diagnostic apparatus for analyzing and measuring electrolytes in the bodymedical diagnostic apparatus for analyzing and measuring blood coagulationmedical diagnostic apparatus for analyzing and measuring urinebloodfecessalivacerebrospinal fluid; ophthalmometers; ophthalmoscopes; Uterine syringe for artificial insemination; blood transfusion apparatus; dialyzers
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/07/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/10/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/02/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/02/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/02/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/02/2020
FIMP
FINAL DISPOSITION PROCESSED
03/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
30/08/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
16/08/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/08/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/05/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
26/04/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2019
PUBO
PUBLISHED FOR OPPOSITION
02/04/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/02/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
22/02/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/02/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
22/02/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/02/2019
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
06/02/2019
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
06/02/2019
CNCF
ACTION CONTINUING A FINAL - COMPLETED
06/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/01/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/01/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/01/2019
GNFR
FINAL REFUSAL E-MAILED
02/01/2019
CNFR
FINAL REFUSAL WRITTEN
02/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/11/2018
ALIE
ASSIGNED TO LIE
26/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/11/2018
RFNT
REFUSAL PROCESSED BY IB
13/10/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/09/2018
RFRR
REFUSAL PROCESSED BY MPU
21/09/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/09/2018
MAFR
APPLICATION FILING RECEIPT MAILED
18/09/2018
CNRT
NON-FINAL ACTION WRITTEN
17/09/2018
DOCK
ASSIGNED TO EXAMINER
12/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZYBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.